Comparison of Two Electroencephalograms (EEG) Monitors in Patients Undergoing General Anesthesia With Sevoflurane
Bis-qCon-Hal
2 other identifiers
interventional
46
1 country
1
Brief Summary
Quantium Medical Company has an ElectoEcenphalograph-based (EEG-based) algorithm with two outputs: qCON for unconsciousness and qNOX for anti-nociception. qCON, is designed to provide information about the depth of the hypnotic state, similar to that provided by the BIS™.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2017
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 6, 2017
CompletedStudy Start
First participant enrolled
November 21, 2017
CompletedFirst Posted
Study publicly available on registry
December 2, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 16, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
March 16, 2018
CompletedAugust 24, 2018
November 1, 2017
4 months
November 6, 2017
August 23, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
qCON monitoring during maintenance of anesthesia
Measurement of qCON values
up to 10 hours
Secondary Outcomes (10)
BIS monitoring during maintenance of anesthesia
One day
qCON monitoring during induction of anesthesia
One day
BIS monitoring during induction of anesthesia
One day
qCON monitoring during recovery of anesthesia
One day
BIS monitoring during recovery of anesthesia during recovery of anesthesia
One day
- +5 more secondary outcomes
Study Arms (1)
qCON monitor
EXPERIMENTALSimultaneous measurement of BIS and qCON
Interventions
Eligibility Criteria
You may qualify if:
- Patients affiliated to a national insurance scheme or benefiting from such a program
- Patients having given their written consent.
- Patients that must benefit from a general anesthesia with the aim of a surgical act of a duration of at least one hour
- Patients that must benefit from a general anesthesia including a maintenance by the sevoflurane.
- For the patients taken care in ambulatory surgery, having a telephone and agreeing to communicate their phone number
You may not qualify if:
- Pregnant or breast-feeding Women
- Patients having a limit of use of the Bispectral Index (BIS) or qCON monitor ,
- Patients having a contraindication in the propofol.
- Patients taken care in ambulatory surgery who could not be contacted within 24 hours following the surgical operation;
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hopital Fochlead
Study Sites (1)
Hopital Foch
Suresnes, 92150, France
Study Officials
- PRINCIPAL INVESTIGATOR
Faiz Sofian, MD
Hopital Foch
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 6, 2017
First Posted
December 2, 2017
Study Start
November 21, 2017
Primary Completion
March 16, 2018
Study Completion
March 16, 2018
Last Updated
August 24, 2018
Record last verified: 2017-11
Data Sharing
- IPD Sharing
- Will not share